Adenovirus-Mediated Interferon-γTransfer Inhibits Growth of Transplanted HTLV-1 Tax Tumors in Mice
- 1 March 1996
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 7 (4) , 471-477
- https://doi.org/10.1089/hum.1996.7.4-471
Abstract
Human T cell leukemia virus type 1 (HTLV-1) causes adult T cell leukemia (ATL), and the virus-encoded trans-activator, Tax, plays an important role in T cell transformation. In the HTLV-1 long terminal repeat (LTR)–Tax transgenic mouse model, Tax expression causes fibroblastic tumors. A tumor-derived cell line (B line) obtained from an explant of a Tax-transformed tumor, was established. This line expresses high levels of many cytokines as a consequence of Tax activation. However, the tumors are not immunogenic when transplanted into syngeneic mice. Because B line cells do not express the immunogenic cytokine interferon-γ (IFN-γ), a replication-defective adenoviral vector was used to deliver the IFN-γ gene to tumor cells. The recombinant IFN-γ adenovirus (IFN-γ/Ad) can efficiently infect B line cells, resulting in high levels of IFN-γ expression and secretion. Local secretion of IFN-γ from B line cells caused both CD4+- and CD8+-positive T cell infiltration, and completely inhibited local tumor development in transplanted mice. Immunization with these cells significantly delayed tumor development after subsequent challenges of parental tumor cells. Expression of IFN-γ in B cells also partially inhibited the highly expressed immune suppressive cytokine, transforming growth factor-β1 (TGF-β1). This system provides us with a valuable tumor immune therapy model to evaluate the effects of cytokines in induction or inhibition of specific antitumor immunity. Human T cell leukemia virus type 1 (HTLV-1) Tax gene expression in transgenic mice causes fibroblastic tumors. A tumor-derived cell line derived from these mice expresses many cytokines other than interferon-γ (IFN-γ), but is not immunogenic. A replication-defective adenovirus was used to direct expression of the IFN-γ gene in tumor cells. Local secretion of IFN-γ caused both CD4+ and CD8+ T cell infiltration, partial inhibition of TGF-β, and completely inhibited local tumor development in transplanted mice. Immunization with these cells significantly delayed tumor development after parental tumor cell challenges.Keywords
This publication has 15 references indexed in Scilit:
- Potential for Interferon-α-Based Therapy in Mesothelioma: Assessment in a Murine ModelJournal of Interferon & Cytokine Research, 1995
- Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression.Proceedings of the National Academy of Sciences, 1995
- Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction.The Journal of Experimental Medicine, 1995
- Human tumor vaccines and genetic engineering of tumors with cytokine and histocompatibility genes to enhance immunogenicityCurrent Opinion in Oncology, 1994
- Inhibition of murine nephritogenic effector T cells by a clone-specific suppressor factor.Journal of Clinical Investigation, 1994
- Direct Gene Transfer for the Understanding and Treatment of Human DiseaseAnnals of the New York Academy of Sciences, 1994
- Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo.Proceedings of the National Academy of Sciences, 1994
- Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma.The Journal of Experimental Medicine, 1993
- Ablation of Transplanted HTLV-I Tax-Transformed Tumors in Mice by Antisense Inhibition of NF-κBScience, 1992
- A Transgenic Mouse Model for Human NeurofibromatosisScience, 1987